Cardiac Valve Repairs - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 9

2 Introduction 10

• 2.1 Cardiac Valve Repairs Overview 10

3 Products under Development 11

• 3.1 Cardiac Valve Repairs - Pipeline Products by Stage of Development 11
• 3.2 Cardiac Valve Repairs - Pipeline Products by Segment 12
• 3.3 Cardiac Valve Repairs - Pipeline Products by Territory 13
• 3.4 Cardiac Valve Repairs - Pipeline Products by Regulatory Path 14
• 3.5 Cardiac Valve Repairs - Pipeline Products by Estimated Approval Date 15
• 3.6 Cardiac Valve Repairs - Ongoing Clinical Trials 16

4 Cardiac Valve Repairs - Pipeline Products under Development by Companies 17

• 4.1 Cardiac Valve Repairs Companies - Pipeline Products by Stage of Development 17
• 4.2 Cardiac Valve Repairs - Pipeline Products by Stage of Development 19

5 Cardiac Valve Repairs Companies and Product Overview 21

• 5.1 Abbott Vascular Inc Company Overview 21
  • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.2 Affluent Medical SA Company Overview 24
  • 5.2.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.3 Ample Medical Inc Company Overview 27
  • 5.3.1 Ample Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.4 Ancora Heart Inc Company Overview 28
  • 5.4.1 Ancora Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 28
• 5.5 BioStable Science & Engineering, Inc. Company Overview 32
  • 5.5.1 BioStable Science & Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.6 Cardiosolutions Inc Company Overview 35
  • 5.6.1 Cardiosolutions Inc Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.7 Celyad SA Company Overview 36
  • 5.7.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview 36
• 5.8 Children's Hospital Boston Company Overview 38
  • 5.8.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.9 Collplant Biotechnologies Ltd Company Overview 41
  • 5.9.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.10 CoreMedic AG Company Overview 42
  • 5.10.1 CoreMedic AG Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.11 CUBE SRL Company Overview 45
  • 5.11.1 CUBE SRL Pipeline Products & Ongoing Clinical Trials Overview 45
• 5.12 Daidalos Solutions BV Company Overview 46
  • 5.12.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 46
• 5.13 Edwards Lifesciences Corp Company Overview 48
  • 5.13.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.14 Emory University Company Overview 53
  • 5.14.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 53
• 5.15 Georgia Institute of Technology Company Overview 54
  • 5.15.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 54
• 5.16 Hangzhou DeJin Medtech Co Ltd Company Overview 55
  • 5.16.1 Hangzhou DeJin Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
• 5.17 Mardil Medical, Inc. Company Overview 57
  • 5.17.1 Mardil Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
• 5.18 Mayo Clinic Company Overview 60
  • 5.18.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 60
• 5.19 MiCardia Corp Company Overview 61
  • 5.19.1 MiCardia Corp Pipeline Products & Ongoing Clinical Trials Overview 61
• 5.20 Michigan Critical Care Consultants, Inc. Company Overview 62
  • 5.20.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
• 5.21 Micro Interventional Devices, Inc. Company Overview 64
  • 5.21.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
• 5.22 Millipede LLC Company Overview 68
  • 5.22.1 Millipede LLC Pipeline Products & Ongoing Clinical Trials Overview 68
• 5.23 Mitralix Ltd. Company Overview 71
  • 5.23.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 71
• 5.24 Mitre Medical Corp Company Overview 74
  • 5.24.1 Mitre Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 74
• 5.25 Neochord Inc Company Overview 76
  • 5.25.1 Neochord Inc Pipeline Products & Ongoing Clinical Trials Overview 76
• 5.26 Rambam Health Care Campus Company Overview 81
  • 5.26.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 81
• 5.27 ReCor Medical Inc Company Overview 82
  • 5.27.1 ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 82
• 5.28 Strait Access Technologies (Pty) Ltd Company Overview 83
  • 5.28.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 83
• 5.29 Symetis SA Company Overview 84
  • 5.29.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview 84
• 5.30 TransCardiac Therapeutics, LLC Company Overview 85
  • 5.30.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
• 5.31 Transmural systems LLC Company Overview 86
  • 5.31.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 86
• 5.32 TTK Healthcare Ltd Company Overview 89
  • 5.32.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 89
• 5.33 University of Manitoba Company Overview 90
  • 5.33.1 University of Manitoba Pipeline Products & Ongoing Clinical Trials Overview 90
• 5.34 Valcare Medical Company Overview 91
  • 5.34.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 91
• 5.35 valsculp Company Overview 93
  • 5.35.1 valsculp Pipeline Products & Ongoing Clinical Trials Overview 93
• 5.36 Valtech Cardio Ltd Company Overview 94
  • 5.36.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
• 5.37 Viacor Inc Company Overview 101
  • 5.37.1 Viacor Inc Pipeline Products & Ongoing Clinical Trials Overview 101

6 Cardiac Valve Repairs- Recent Developments 102

• 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 102
• 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 104
• 6.3 Oct 23, 2019: Edwards Lifesciences reports third quarter results 105
• 6.4 Oct 22, 2019: CollPlant CEO Yehiel Tal appointed to serve on international society for Biofabrication's Industry Relations Committee 108
• 6.5 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 108

7 Appendix 154

• 7.1 Methodology 154
• 7.2 About GlobalData 157
• 7.3 Contact Us 157